Tumor cells effectively maintain the intracellular antioxidant state through Nrf2 activation as a result of mutations in genes such as NRF2, KEAP1, and CUL3, which accelerate tumor cell growth and contribute to the development of resistance to anti-tumor drugs [11, 12]. The gene discussed is CUL3; the disease is neoplasm.